Oswald Sonntag

Oswald Sonntag

Auto-generated profile, based on publicly available information

Oswald Sonntag

Independent Consultant , Munich , Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2026 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
HÇHikmet Can Can Çubukçu
Hikmet Can Can Çubukçu
OSOswald Sonntag
Oswald Sonntag
NLNathan Lorde
Nathan Lorde
CLCharles Lefèvre
Charles Lefèvre
CCChiara Cosma
Chiara Cosma
Mario PlebaniMario Plebani
Mario Plebani
Background: Patient risk management has become central to clinical laboratory quality standards, including the Clinical and Laboratory Standards Institute (CLSI) EP23 2nd edition (CLSI EP23-ED2), International Organization for Standardization (ISO) 15189:2022, ISO 22367:2026, and ISO 14971:2019. A key component of risk analysis is estimating the severity of harm (SoH) that may result from erroneous laboratory results. We present here the Severity of Harm Evidence Database, a structured, multi-study resource that integrates survey-based SoH assessments from the published independent studies. The database provides ordinal distributions and pooled SoH for 196 unique laboratory tests. Methods: A canonical five-level scale (negligible, minor, serious, critical, catastrophic) was adopted, aligned with ISO 14971:2019. For the 19 tests common to both studies, direct count pooling was performed by summing category-level respondent counts. Wilson score confidence intervals were calculated for all proportions. The database is organized into nine relational sheets and is accompanied by an interactive web application. Results: Out of the 196 tests covered, 19 have pooled estimates from both studies (total n=781 respondents). Pooled analysis confirms that cardiac biomarkers, blood gases, coagulation parameters, electrolytes (potassium, sodium), and therapeutic drug concentrations (digoxin, lithium) consistently receive the highest severity ratings, while certain endocrine markers receive lower scores. Conclusions: The SoH evidence database offers the first publicly available, structured repository of SoH assessments for clinical laboratory tests. It supports compliance with risk management requirements, informs risk-based strategies per CLSI EP23-ED2, and provides an evidence-based foundation for laboratory risk analysis.

27 July 2026 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
OSOswald Sonntag
Oswald Sonntag
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi

28 October 2026 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
OSOswald Sonntag
Oswald Sonntag
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
CLCharles Lefèvre
Charles Lefèvre
HÇHikmet Can Can Çubukçu
Hikmet Can Can Çubukçu
Mario PlebaniMario Plebani
Mario Plebani
NLNathan Lorde
Nathan Lorde
Background: Hemolysis is a major preanalytical source of laboratory interference, but methods used to experimentally generate hemolyzed specimens are poorly standardized. Content: Different lysis procedures, blood sources, cellular compositions, hemolysate volumes, control designs, and time-to-analysis can influence results independently of free hemoglobin concentration. The amount and composition of intracellular material released may also vary with erythrocyte, leukocyte, and platelet characteristics. Therefore, identical hemolysis indices do not necessarily represent equivalent experimental interferents. Summary: Hemolysis interference studies should clearly distinguish the interferent, its method of generation, and its measurement. Detailed reporting of specimen preparation and experimental conditions is essential for reproducibility and comparison between studies. Outlook: Harmonized hemolysate preparation and reporting, together with assessment at clinically relevant measurand concentrations and, when appropriate, multiple time points, would improve the reliability of hemolysis thresholds and laboratory decision-making.

11 November 2026 in Diagnosis
Verified
Journal Article
Closed access
OSOswald Sonntag
Oswald Sonntag
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi

16 November 2026 in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
Verified
Journal Article
Open access
OSOswald Sonntag
Oswald Sonntag
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi

11 July 2025 in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
Verified
Journal Article
Closed access
OSOswald Sonntag
Oswald Sonntag